Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Change in Receivables (2016 - 2025)

Bio Key International's Change in Receivables history spans 16 years, with the latest figure at -$89475.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 529.05% year-over-year to -$89475.0; the TTM value through Sep 2025 reached -$879697.0, down 1455.64%, while the annual FY2024 figure was -$855829.0, 299.61% down from the prior year.
  • Change in Receivables for Q3 2025 was -$89475.0 at Bio Key International, down from -$69743.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $904930.0 in Q1 2022 and bottomed at -$877490.0 in Q2 2022.
  • The 5-year median for Change in Receivables is -$4000.0 (2021), against an average of -$9096.2.
  • The largest YoY upside for Change in Receivables was 8600.99% in 2022 against a maximum downside of 284799.35% in 2022.
  • A 5-year view of Change in Receivables shows it stood at -$4000.0 in 2021, then surged by 1968.7% to $74748.0 in 2022, then tumbled by 108.36% to -$6247.0 in 2023, then tumbled by 12794.62% to -$805527.0 in 2024, then skyrocketed by 88.89% to -$89475.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Change in Receivables are -$89475.0 (Q3 2025), -$69743.0 (Q2 2025), and $85048.0 (Q1 2025).